Results 321 to 330 of about 152,832 (396)

High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes.

open access: yesJ Clin Endocrinol Metab
Cremaschi A   +11 more
europepmc   +1 more source

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

open access: yesBritish Journal of Pharmacology, 2018
Debbie L Hay   +2 more
exaly   +2 more sources

Anti‐migraine Calcitonin Gene–Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice

open access: yesAnnals of Neurology, 2020
Calcitonin gene–related peptide (CGRP) pathway inhibitors are emerging treatments for migraine. CGRP‐mediated vasodilation is, however, a critical rescue mechanism in ischemia.
Inge A Mulder   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine

open access: yesPain, 2017
Calcitonin gene–related peptide (CGRP) is a 37-amino acid peptide found primarily in the C and Aδ sensory fibers arising from the dorsal root and trigeminal ganglia, as well as the central nervous system. Calcitonin gene–related peptide was found to play
S. Iyengar, M. Ossipov, Kirk W. Johnson
exaly   +2 more sources

The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects

open access: yesFrontiers in Physiology, 2018
Calcitonin gene-related peptide (CGRP) is a highly potent vasoactive peptide released from sensory nerves, which is now proposed to have protective effects in several cardiovascular diseases.
Zizheng Kee, Susan D Brain
exaly   +2 more sources

Home - About - Disclaimer - Privacy